Presentation by Ambassador Stephen Lewis, co-director, AIDS-Free World and U.N. special envoy for HIV/AIDS in Africa (2001-2006), follow by panel discussion and reception. Lewis will be introduced by UCSF Chancellor Susan Desmond-Hellmann, MD, MPH.
A recent two-day symposium at UCSF offered leading stem cell experts a chance to talk shop and form new alliances in the fight against neurological disorders.
From anxiety to exhilaration to burgers with the boss, the 14 members of Elizabeth Blackburn's lab share the exciting hours surrounding the Oct. 5 Nobel Prize announcement.
Dean Schillinger, director of the UCSF Center for Vulnerable Populations (CVP) at San Francisco General Hospital, received a national award for research leading to better communication in health care.
The University of California, San Francisco has been designated to lead a new consortium that will study a group of severe immune disorders known as primary immunodeficiencies and aims to improve treatment for these often life-threatening diseases. The Primary Immune Deficiency Treatment Consortium comprises 13 centers throughout the United States and has a $6.25 million funding commitment over five years from the National Institutes of Health.